வெட்டு சிகிச்சை News Today : Breaking News, Live Updates & Top Stories | Vimarsana
HemoShear Therapeutics Advancing Several Novel Compounds for Horizon Therapeutics plc Gout Discovery Pipeline
prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.
HemoShear Therapeutics Announces First Two Patients Dosed in Phase 2 Study of Oral Small Molecule HST5040 for Methylmalonic Acidemia (MMA) and Propionic Acidemia (PA)
prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.
HemoShear Therapeutics Advances Second Novel Drug Target into Horizon Therapeutics plc Early Discovery Pipeline for Gout
- Second Milestone Achieved by HemoShear in Exclusive Drug Discovery Collaboration -
News provided by
Share this article
CHARLOTTESVILLE, Va., April 21, 2021 /PRNewswire/
HemoShear Therapeutics, Inc., a privately held clinical stage biotechnology company, has identified a second drug target for the treatment of gout under its collaboration with Horizon Therapeutics plc (Nasdaq: HZNP) that was established in January 2019. Leveraging its proprietary
REVEAL-Tx™ disease modeling platform, HemoShear has earned two milestone payments to date in accordance with the Horizon exclusive drug discovery agreement. Each milestone acknowledges the validation of a novel drug target and its advancement to a subsequent stage in Horizon s early discovery pipeline.
HemoShear Therapeutics Raises $40 Million in Series A Financing to Advance Rare Disease Portfolio
~ Suvretta Capital Leads Financing with Janus Henderson Investors and Adage Capital Management Joining Syndicate
News provided by
Share this article
Share this article
CHARLOTTESVILLE, Va., Feb. 10, 2021 /PRNewswire/ HemoShear Therapeutics, Inc., a clinical stage company developing treatments for rare metabolic disorders, has raised $40 million in a Series A financing. Suvretta Capital led the financing along with Janus Henderson Investors, Adage Capital Management LP and other private investors. The Series A funding will enable the company to complete a phase 2 study of its lead compound, HST5040, for the treatment of methylmalonic acidemia (MMA) and propionic acidemia (PA), as well as fund future clinical studies and earlier stage programs.
Salon pivots to stay alive amid pandemic
Courtesy of Stephanie James
Shear Therapy owner Stephanie James has reimagined her business in response to the pandemic.
After being forced to close her salon for a third time during the pandemic, Shear Therapy owner Stephanie James has tweaked her business model to keep her downtown Los Altos shop afloat amid these challenging times.
Shear Therapy, located at 184 Plaza South, was once a four-chair hair salon, with James working two chairs and two other stylists renting the other two. However, due to financial problems caused by the pandemic and the departure of one of the stylists, James had to reimagine her salon in an attempt to survive as many small businesses have gone under.
vimarsana © 2020. All Rights Reserved.